Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 23 | 1,212 | 327 | 1,883 | 68 |
| Cost of Goods | 381 | 936 | 529 | 1,224 | 193 |
| Gross Profit | -358 | 276 | -202 | 659 | -125 |
| Operating Expenses | 1,770 | 1,756 | 1,622 | 841 | 1,379 |
| Operating Income | -1,747 | -544 | -1,295 | 42 | -1,311 |
| Interest Expense | 7 | 9 | 10 | 10 | 2 |
| Other Income | 1 | 15 | -29 | -3 | 0 |
| Pre-tax Income | -1,753 | -538 | -1,335 | 29 | -1,313 |
| Net Income Continuous | -1,753 | -538 | -1,335 | 29 | -1,313 |
| Net Income | $-1,753 | $-538 | $-1,335 | $29 | $-1,313 |
| EPS Basic Total Ops | -0.12 | -0.04 | -0.10 | 0.00 | -0.11 |
| EPS Basic Continuous Ops | -0.12 | -0.04 | -0.10 | 0.00 | -0.10 |
| EPS Diluted Total Ops | -0.12 | -0.04 | -0.10 | 0.00 | -0.11 |
| EPS Diluted Continuous Ops | -0.12 | -0.04 | -0.10 | 0.00 | -0.10 |
| EBITDA(a) | $-1,744 | $-540 | $-1,290 | $50 | $-1,327 |